EPHB4 and neoplasm: We have reported that within the HNSCC tumor microenvironment (TME), EphB4 is predominantly expressed in cancer cells and its knockdown or knockout drives local progression by increasing immunosuppressive immune cells in the TME (Bhatia et al., 2022).